Dharuhera Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.81 Cr
- Paid Up Capital ₹ 2.40 Cr
- Company Age 43 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth -3.22%
- Profit Growth -143.70%
- Ebitda -31.74%
- Net Worth 165.09%
- Total Assets 51.30%
About Dharuhera Pharmaceuticals
Dharuhera Pharmaceuticals Pvt Ltd (DPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 March 1981 and has a history of 43 years and ten months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.81 Cr and a paid-up capital of Rs 2.40 Cr.
The company currently has active open charges totaling ₹1.00 M.
Rajpal Kochhar and Main Singh serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239DL1981PTC011495
- Company No.
011495
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dharuhera Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajpal Kochhar  | Director | 12-Sep-2022 | Current |
| Main Singh | Director | 19-Jan-2022 | Current |
Financial Performance of Dharuhera Pharmaceuticals.
Dharuhera Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.22% decrease. The company also saw a substantial fall in profitability, with a 143.7% decrease in profit. The company's net worth Soared by an impressive increase of 165.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dharuhera Pharmaceuticals?
In 2023, Dharuhera Pharmaceuticals had a promoter holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suvinys Developers Private LimitedRajpal Kochhar is a mutual person
Aresko Restaurants Private LimitedRajpal Kochhar is a mutual person
Raipur Lodge Private LimitedRajpal Kochhar is a mutual person
Kila Tatarpur Hotels Private LimitedRajpal Kochhar is a mutual person
I.K. Enterprises Private LimitedRajpal Kochhar is a mutual person
Aresko Management LlpRajpal Kochhar is a mutual person
Charges (Loans)
₹0.10 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 1986 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Dharuhera Pharmaceuticals?
Dharuhera Pharmaceuticals has a workforce of 34 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dharuhera Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dharuhera Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
